等待開盤 03-26 09:30:00 美东时间
+1.590
+5.64%
U.S. mid-cap stocks have delivered solid year-to-date performance amid favorable economic conditions and broadening market participation, despite recent volatility due to geopolitical challenges. In l...
03-24 02:47
Stocks fall, Nasdaq drops 200 points. Apogee Therapeutics (APGE) rises 19.4% on positive trial data. Satellogic (SATL), YD Bio (YDES), AXT Inc (AXTI) also see gains.
03-23 22:45
Insiders have been trading these 5 stocks: (($FSLY)), (($NEM)), (($ON)), (($BE)...
03-21 21:00
As the fourth-quarter earnings season winds down, investors are turning their attention to updated quant ratings following the latest round of corporate results. The quant scores provide a snapshot of...
03-15 00:50
Management says AI is becoming an increasing tailwind for the business as demand grows for tools that help manage automated and AI-driven internet traffic.
03-10 03:47
Insiders have been trading these 5 stocks: (($FSLY)), (($TTWO)), (($SMR)), (($W...
03-07 21:01
Fastly Dismisses Deloitte as Auditor and Names KPMG as Replacement Fastly Inc. said its audit committee has dismissed Deloitte & Touche LLP as its independent registered public accounting firm and approved the appointment of KPMG LLP for the fiscal year ending Dec. 31, 2026, subject to KPMG completi
03-05 22:13
今日重点评级关注:HC Wainwright & Co.:维持Helus Pharma"买入"评级,目标价从55美元升至95美元;HC Wainwright & Co.:维持Compass Pathways"买入"评级,目标价从40美元升至70美元
03-03 20:22
RBC Capital analyst Rishi Jaluria maintains Fastly (NASDAQ:FSLY) with a Sector Perform and raises the price target from $12 to $20.
03-03 00:22
U.S. RESEARCH ROUNDUP- Aardvark Therapeutics, Chevron, Crowdstrike Mar 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aardvark Therapeutics , Chevron and Crowdstrike, on Monday. HIGHLIGHTS * Aardvark Therapeutics Inc
03-02 15:29